Exceptional Matters: Clinical Research from Bedside to Bench

Total Page:16

File Type:pdf, Size:1020Kb

Exceptional Matters: Clinical Research from Bedside to Bench I COLLEGE LECTURES Exceptional Matters: clinical research from bedside to bench Keith Peters Introduction ...a word of counsel to beginners, it is: ‘Treasure your exceptions! When there are none, work gets so dull that no In his Harveian Oration of exactly 80 years ago, one cares to carry it further. Keep them always uncovered Archibald Garrod, one of the greatest clinical and in sight. Exceptions are like the rough brick-work of a researchers of the last century, quoted from a letter growing building which tells that there is more to come written by Harvey (only six weeks before his death) and shews where the next construction is to be’. to a Dutch physician who had sent him an unusual specimen:1 Garrod’s Oration in 1924 was titled The debt of sci- ence to medicine. Today’s catch-phrase is ‘from bench The Harveian It is even so – Nature is nowhere accustomed more openly to bedside’ and university medical centres are strug- Oration is given to display her secret mysteries than in cases where she gling with the promotion of translational research. annually at the shows traces of her workings apart from the beaten path; But in the relatively recent past, the debt of science to Royal College of nor is there any better way to advance the proper practice medicine has in fact grown more than even Garrod Physicians of London under an of medicine than to give our minds to the discovery of the might have envisaged – often in the most surprising indenture of usual law of Nature, by careful investigation of cases of ways. rarer forms of disease. For it has been found, in almost all William Harvey in I shall describe examples which reflect a largely 1656. This article things, that what they contain of useful or applicable is personal experience, where astute observations of is based on the hardly perceived unless we are deprived of them, or they single cases or small groups of patients have been the 2004 Oration become deranged in some way. starting point of voyages of scientific discovery – given on 19 Garrod then went on : from, as it were, the bedside to the bench – but in October 2004 by doing so I shall illustrate the synergy between clinical Sir Keith Peters These words, as true to-day as when they were written, are and basic biomedical research that now provides FRCP FRS PMedSci, full of encouragement for those of us for whom the study of medical scientists with investigative tools of hitherto Regius Professor of Physic, Head of the Nature’s experiments and mistakes has a special attrac- unimagined power. Indeed, I hope to persuade you tion. The structural malformation, or the hereditary and School of Clinical that the golden age of clinical science does not belong inborn departure from the normal of metabolism, Medicine, to a long-gone era but that it is about to begin. although unimportant from the practical standpoint, may University of My professional life has been divided into two Cambridge throw a ray of light into some dark place of embryology or overlapping phases: the first as a practising physi- biochemistry; and not a few of the rare maladies, such as cian/clinical scientist, and the second with strategic chloroma, polycythaemia vera, sulphaemoglobinaemia, Clin Med JRCPL responsibilities for teaching and research at the Royal 2004;4:551–66 and the disease of which Bence-Jones albuminuria is a Postgraduate Medical School (RPMS) and at the sign, offer fascinating and still unsolved problems of Clinical School in Cambridge. I hope to show some- physiology and pathology. thing of the power of blending the values and cul- The force of these much-quoted observations remains tures of the two institutions: the RPMS, the crucible undiminished today. of clinical science, pioneering medical technology Garrod, stimulated by the black urine of a patient and providing the breeding ground for leaders in with alcaptonuria, introduced the concept of the clinical academic medicine, and Cambridge with its inborn error of metabolism. Influenced by William tradition of basic medical science, especially molec- Bateson, he suggested that inborn errors are caused ular and cell biology. by (genetic) defects in enzymes: his 1908 inference I was an undergraduate in Cardiff where I was that genes encode enzymes antedated by 35 years the taught by Harold Scarborough, the Professor of Nobel Prize winning rediscovery by Beadle and Medicine. He was then well known to medical stu- Tatum.2 dents as the co-author of ‘BDS’: Bell, Davidson and I believe I can be confident that my title would Scarborough, Textbook of physiology and biochem- have found approval with Garrod, and Harvey and istry. He was an exceptional teacher who sought to Bateson. Bateson declared:3 explain disease in physiological and biochemical Clinical Medicine Vol 4 No 6 November/December 2004 551 Keith Peters terms. I also saw a great deal of Archie Cochrane, for he invited nisms of disease in nephritis, then the principal cause of end- our small band of medical students to his elegant home and stage renal failure, and application of Dixon’s ideas was a natural tried passionately to convert us to epidemiology by proselytising starting point. Antibodies to GBM were usually associated with the virtues of the randomised clinical trial. He had few total a devastating disease (Goodpasture’s syndrome) in which the converts but his influence was enduring. lung basement membranes were also damaged causing life- In 1965, I moved to Birmingham to join John Squire in the threatening pulmonary haemorrhage, and where kidney func- Department of Experimental Pathology; this was my first expo- tion was rapidly lost due to a severe proliferative nephritis sure to experimental models of disease in animals. Squire was in (rapidly progressive glomerulonephritis (RPGN)). We reasoned every way exceptional and was planning, as Director Designate, that if circulating autoantibodies were indeed the cause of dis- the MRC Clinical Research Centre at Northwick Park, but sadly ease, then interventions aimed at reducing their generation – died five months later. Memorably, I met Emil Unanue who had immunosuppression, combined with plasma exchange to gone to work with John Humphrey at Mill Hill but had earlier, remove antibody – should alleviate the disease.6 with Frank Dixon, conducted comprehensive and definitive The surprising finding was not that disease was alleviated but studies of experimental models of nephritis.4,5 Unanue, Frank that antibody production was permanently arrested in some Austen and Hugh McDevitt, who also worked with John patients in less than a few weeks (Fig 1). It has taken many years Humphrey, have become leading immunologists in the USA: of research into immunoregulatory mechanisms to begin to they acknowledge the scientific inspiration that John unselfishly throw light on how this might have been brought about. Only in provided. John Humphrey was later to become Professor of the last decade has there been a convincing characterisation of Immunology at the RPMS in succession to Peter Lachmann. regulatory T cells whose engagement (shifting the balance Frank Dixon had established the paradigm for pathogenetic between activatory and regulatory T cells) could explain the ter- mechanisms in glomerulonephritis – namely that there were mination of an autoimmune response. The subject of regulatory two underlying immunological mechanisms, the first mediated T cells is now a major area of immunological research – and by autoantibodies (especially to glomerular basement mem- devising immunological interventions specifically to promote brane (GBM)) and the second due to accumulation in the the generation of immunological control systems to suppress glomerulus of circulating antigen–antibody complexes – unwanted immune responses, including immune responses to immune complex disease; and that these two processes were transplanted organs, is a major goal of modern immunology.7 readily distinguishable by immunofluorescent examination of (It should be added that despite thousands of publications on renal biopsies. the subject of regulatory T cells in mice there is as yet no test which identifies their specific functional presence in regulating From experimental models to the clinic: autoimmune disorders in man.) autoimmunity and plasma exchange Success in the anti-GBM syndromes led to a consideration of other diseases where patients were not critically ill and were I was appointed to a lectureship in renal medicine at the RPMS therefore easier to evaluate. The first of these was myasthenia in 1969 with the intention of developing research into mecha- gravis (MG), then suspected though not proven to be due to Prednisone Cyclophosphamide Dialysis Plasmapheresis 16 700 14 600 12 Creatinine ( 500 10 Creatinine 400 8 µ 300 mol/l) 6 Anti–GBM antibody 200 4 Anti–GBM antibody 100 (% binding by radioimmunoassy) (% binding by 2 NORMAL Fig 1. Effect of plasma exchange and RANGE 0 0 immunosuppression on anti-GBM antibody 22 31 7 14 21 28 7 15 5 and renal function. Autoantibody production Aug Sept Oct Dec ceased and never recurred (from Ref 6). 552 Clinical Medicine Vol 4 No 6 November/December 2004 Exceptional Matters autoantibodies to the acetylcholine receptor (AChR). Tony was flimsy; nevertheless, cytotoxic drugs such as cyclophos- Pinching, who had worked with John Newsom-Davis as a junior phamide seemed beneficial. Since it could be argued that certain doctor at Queen Square, suggested that we invite John to collab- plasma protein constituents, such as complement and fibrin- orate. To our delight, there
Recommended publications
  • The Future Role of Molecular and Cell Biology in Medical Practice in the Tropical Countries
    The future role of molecular and cell biology in medical practice in the tropical countries David Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK Downloaded from https://academic.oup.com/bmb/article/54/2/489/285007 by guest on 27 September 2021 Molecular and cell biology have a great deal to offer tropical medicine in the future. As well as helping to understand the population genetics and dynamics of both infectious and non-infectious diseases, they promise to provide a new generation of diagnostic and therapeutic agents, and to play a major role in the development of new vaccines and other approaches to the control of disease in tropical communities. Over the last 20 years there has been a gradual shift in the emphasis of basic biomedical research from the study of disease in patients and their organs to its definition at the level of molecules and cells. This new trend has been underpinned by a remarkable new technology which has made it possible to isolate and sequence genes, study their function and transfer them across the species barrier. In the short time during which this field has evolved, a great deal has been discovered about human pathology at the molecular level. Many monogenic diseases have been characterised, much has been learnt about the molecular and cell biology of cancer, and a start has been made in defining the different genes that comprise the complex interactions between nature and nurture that underlie many of the major killers of Western society. Enough is known already to suggest that this knowledge will have major implications for the development of more precise diagnostic and therapeutic agents in the future.
    [Show full text]
  • The Use of Non-Human Primates in Research in Primates Non-Human of Use The
    The use of non-human primates in research The use of non-human primates in research A working group report chaired by Sir David Weatherall FRS FMedSci Report sponsored by: Academy of Medical Sciences Medical Research Council The Royal Society Wellcome Trust 10 Carlton House Terrace 20 Park Crescent 6-9 Carlton House Terrace 215 Euston Road London, SW1Y 5AH London, W1B 1AL London, SW1Y 5AG London, NW1 2BE December 2006 December Tel: +44(0)20 7969 5288 Tel: +44(0)20 7636 5422 Tel: +44(0)20 7451 2590 Tel: +44(0)20 7611 8888 Fax: +44(0)20 7969 5298 Fax: +44(0)20 7436 6179 Fax: +44(0)20 7451 2692 Fax: +44(0)20 7611 8545 Email: E-mail: E-mail: E-mail: [email protected] [email protected] [email protected] [email protected] Web: www.acmedsci.ac.uk Web: www.mrc.ac.uk Web: www.royalsoc.ac.uk Web: www.wellcome.ac.uk December 2006 The use of non-human primates in research A working group report chaired by Sir David Weatheall FRS FMedSci December 2006 Sponsors’ statement The use of non-human primates continues to be one the most contentious areas of biological and medical research. The publication of this independent report into the scientific basis for the past, current and future role of non-human primates in research is both a necessary and timely contribution to the debate. We emphasise that members of the working group have worked independently of the four sponsoring organisations. Our organisations did not provide input into the report’s content, conclusions or recommendations.
    [Show full text]
  • Downloaded and Ready for Use As Soon As the Grade 8S Received - VHS Video on Landforms Their Shiny New Laptops
    THE HILTONIAN EDITION 154 APRIL 2019 Contents Board of Governors, Staff and Salvete 2018 4 The Hilton Year 19 Academic Affairs 58 Sport 107 Old Hiltonian News 177 1 2 12 Foreword Within every great institution, the compilation of each year’s On the sporting front, our boys did remarkably. Most history is integral to its grand story. It’s a privilege for me to importantly, all are engaged and learning, whether they're be a part of this particular grand story. 2018 turned out to be playing for the As or the Ds. Our 1st XV had a tremendous a superb year for Hilton College. unbeaten season worthy of celebration. We've also made great strides in our basketball and soccer offerings, which all Our bold vision is to deliver on A Plan for Every Hilton Boy. our boys enjoy. This brave strategy aims to ensure that each boy is understood and then challenged appropriately to work The various reports in this edition of the Hiltonian serve as a towards developing his best version of himself. While we record of events and achievements, but I also hope they continuously work on refining this strategy, we're proud of the convey some of the spirit of this great school which continues fact that each Hilton boy can feel that he has some autonomy to mould boys into young men, ready to take on the world. in his choices and in achieving his personal dreams. Hilton College, founded to raise gentlemen and simultaneously Academically, we embraced a new approach to teaching our serve as a beacon of hope to its surrounding community, is grade 8s and 9s, redesigning the curriculum with an intentional achieving its aims.
    [Show full text]
  • Clinical Genetics in Britain: Origins and Development
    CLINICAL GENETICS IN BRITAIN: ORIGINS AND DEVELOPMENT The transcript of a Witness Seminar held by the Wellcome Trust Centre for the History of Medicine at UCL, London, on 23 September 2008 Edited by P S Harper, L A Reynolds and E M Tansey Volume 39 2010 ©The Trustee of the Wellcome Trust, London, 2010 First published by the Wellcome Trust Centre for the History of Medicine at UCL, 2010 The Wellcome Trust Centre for the History of Medicine at UCL is funded by the Wellcome Trust, which is a registered charity, no. 210183. ISBN 978 085484 127 1 All volumes are freely available online following the links to Publications/Wellcome Witnesses at www.ucl.ac.uk/histmed CONTENTS Illustrations and credits v Abbreviations vii Witness Seminars: Meetings and publications; Acknowledgements E M Tansey and L A Reynolds ix Introduction Sir John Bell xix Transcript Edited by P S Harper, L A Reynolds and E M Tansey 1 Appendix 1 Initiatives supporting clinical genetics, 1983–99 by Professor Rodney Harris 83 Appendix 2 The Association of Genetic Nurses and Counsellors (AGNC) by Professor Heather Skirton 87 References 89 Biographical notes 113 Glossary 133 Index 137 ILLUSTRATIONS AND CREDITS Figure 1 Professor Lionel Penrose, c. 1960. Provided by and reproduced with permission of Professor Shirley Hodgson. 8 Figure 2 Dr Mary Lucas, clinical geneticist at the Galton Laboratory, explains a poster to the University of London’s Chancellor, Princess Anne, October 1981. Provided by and reproduced with permission of Professor Joy Delhanty. 9 Figure 3 (a) The karyotype of a phenotypically normal woman and (b) family pedigree, showing three generations with inherited translocation.
    [Show full text]
  • Clinical Molecular Genetics in the Uk C.1975–C.2000
    CLINICAL MOLECULAR GENETICS IN THE UK c.1975–c.2000 The transcript of a Witness Seminar held by the History of Modern Biomedicine Research Group, Queen Mary, University of London, on 5 February 2013 Edited by E M Jones and E M Tansey Volume 48 2014 ©The Trustee of the Wellcome Trust, London, 2014 First published by Queen Mary, University of London, 2014 The History of Modern Biomedicine Research Group is funded by the Wellcome Trust, which is a registered charity, no. 210183. ISBN 978 0 90223 888 6 All volumes are freely available online at www.history.qmul.ac.uk/research/modbiomed/ wellcome_witnesses/ Please cite as: Jones E M, Tansey E M. (eds) (2014) Clinical Molecular Genetics in the UK c.1975–c.2000. Wellcome Witnesses to Contemporary Medicine, vol. 48. London: Queen Mary, University of London. CONTENTS What is a Witness Seminar? v Acknowledgements E M Tansey and E M Jones vii Illustrations and credits ix Abbreviations xi Ancillary guides xiii Introduction Professor Bob Williamson xv Transcript Edited by E M Jones and E M Tansey 1 Appendix 1 Photograph, with key, of delegates attending The Molecular Biology of Thalassaemia conference in Kolimbari, Crete, 1978 88 Appendix 2 Extracts from the University of Leiden postgraduate course Restriction Fragment Length Polymorphisms and Human Genetics, 1982 91 Appendix 3 Archival material of the Clinical Molecular Genetics Society 95 Biographical notes 101 References 113 Index 131 Witness Seminars: Meetings and Publications 143 WHAT IS A WITNESS SEMINAR? The Witness Seminar is a specialized form of oral history, where several individuals associated with a particular set of circumstances or events are invited to meet together to discuss, debate, and agree or disagree about their memories.
    [Show full text]
  • St Catharine's College Society Magazine 1
    CONTENTS Sir Terence English 1 Honours and Awards 2 Editorial 3 The Master Elect, Professor David Ingram; University Appointments 4 Governing Body 5 Cheering up Depressed Mussels. Dr David Aldridge 8 Publications 9 Reviews and Notes 10 The College Staff 15 Dr Robert Evans' 90th Birthday Celebration; St Catharine's Gild 16 St Catharine of Alexandria 17 Arctic Circle Ski Race. Hugh Pritchard 18 College Society Reports 21 The St Catharine's Society: The President Elect and Officers of the Society 25 The St Catharine's Society: The AGM 1999 26 The St Catharine's Society: Mr Tom Cook (Honorary Secretary Retired): Presentation 27 The St Catharine's Society: The AGM 2000 Agenda and Sports Fund 28 The St Catharine's Society: Accounts 29 Weddings Births and Deaths 30 Obituaries 37 Matriculations 1999-2000 40 Postgraduates Registered and PhDs Approved 1999-2000 42 Appointments and Notes 44 M.C.R. and J.C.R 48 The Matterhorn Disaster. A. J. Longford 49 Kittens, Cardinals, and Alley cats. Professor Donald Broom 51 Gifts and Bequests; American & Canadian Friends 52 The College Chapel and Choir 53 The Singing Cats. Paul Griffin 54 The St Catharine's Society: Branch News 55 Down to the Sea in Ships. Captain Charles Styles R.N 56 College Club Reports 58 The University Cross Channel Race 2000 64 Blues 1999-2000 65 An Oxford and Cambridge Boat Race 1950 66 Awards and Prizes 68 Dr Paul Raithby and Chemists 72 Honorary Fellowships: Mr Jeremy Paxman and Professor Jonathan Bate 73 The Editor's Desk 74 Development Campaign 76 Annual Dinners: The Society; The Governing Body Invitation 80 Important Notes and Dates for All Readers 81 Cover: As we step into the new millennium College Main Court on Saturday 17th June 2000.
    [Show full text]
  • Clinical Genetics in Britain: Origins and Development Harper, PS; REYNOLDS, LA; TANSEY, EM
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Queen Mary Research Online Clinical Genetics in Britain: Origins and development Harper, PS; REYNOLDS, LA; TANSEY, EM For additional information about this publication click this link. http://qmro.qmul.ac.uk/jspui/handle/123456789/2823 Information about this research object was correct at the time of download; we occasionally make corrections to records, please therefore check the published record when citing. For more information contact [email protected] CLINICAL GENETICS IN BRITAIN: ORIGINS AND DEVELOPMENT The transcript of a Witness Seminar held by the Wellcome Trust Centre for the History of Medicine at UCL, London, on 23 September 2008 Edited by P S Harper, L A Reynolds and E M Tansey Volume 39 2010 ©The Trustee of the Wellcome Trust, London, 2010 First published by the Wellcome Trust Centre for the History of Medicine at UCL, 2010 The Wellcome Trust Centre for the History of Medicine at UCL is funded by the Wellcome Trust, which is a registered charity, no. 210183. ISBN 978 085484 127 1 All volumes are freely available online at: www.history.qmul.ac.uk/research/modbiomed/wellcome_witnesses/ Please cite as : Reynolds L A, Tansey E M. (eds) (2010) Clinical Genetics in Britain: Origins and development. Wellcome Witnesses to Twentieth Century Medicine, vol. 39. London: Wellcome Trust Centre for the History of Medicine at UCL. CONTENTS Illustrations and credits v Abbreviations vii Witness Seminars: Meetings and publications; Acknowledgements E M Tansey and L A Reynolds ix Introduction Sir John Bell xix Transcript Edited by P S Harper, L A Reynolds and E M Tansey 1 Appendix 1 Initiatives supporting clinical genetics, 1983–99 by Professor Rodney Harris 83 Appendix 2 The Association of Genetic Nurses and Counsellors (AGNC) by Professor Heather Skirton 87 References 89 Biographical notes 113 Glossary 133 Index 137 ILLUSTRATIONS AND CREDITS Figure 1 Professor Lionel Penrose, c.
    [Show full text]
  • Oxford Medicine
    Oxford Medicine THE NEWSLETTER OF THE OXFORD MEDICAL ALUMNI OXFORD MEDICINE • DECEMBER 2019 Courtesy of Ludwig Cancer Research of Ludwig Cancer Courtesy The Regius Professor Sir Tingewick is Does reflects on Peter Ratcliffe 80! Developmental 45 years in FRS, Nobel Dyslexia Really medicine Laureate Exist? 2 / OXFORD MEDICINE DECEMBER 2019 President’s Piece Welcome to the December Sir William Osler’s Centenary commemorations will issue of Oxford Medicine, the continue throughout the year in Oxford and beyond. newsletter for Oxford Medical The Osler Club is the first of a number of thriving Alumni (OMA) who have postgraduate Oxford medical societies we plan to feature. trained, taught, or worked at Professor Terence Ryan summarises this year’s five Osler Oxford. Professor John Morris, Club seminars exploring the Oslerian theme ‘For Health OMA president for the past and Wellbeing, Science and Humanities are one’. six years, handed the baton Tingewick is 80 this year. In 2019, as in 1939, Tingewick to me in September. It is a Dr Lyn Williamson, is still the most inclusive Oxford clinical student society. OMA President daunting task to take over from This year, every first year clinical student took part - someone so beloved and so that is 165! The show was a triumph of teamwork and respected, who has taught anatomy to generations talent. The legacy of camaraderie will last a lifetime - as of Oxford students and postgraduates, and shaped witnessed by the 80th anniversary celebrations. Dr Derek the preclinical school for many years. With his Roskell, Senior Tingewick Member for 25 years adds his characteristic kindness and wisdom, he said: ‘You will be fine - and I will be there to advise you’.
    [Show full text]
  • Combined Book Exhibit® Xxxxxxxxxxxxxxxxxxxxxx
    Welcome to the 2013 London Book Fair at Earls Court, The London Book Fair and the Combined Book Exhibit welcome you to the 7th Annual London Book Fair New Title Showcase. We are proud to present over of 300 print titles and ebook titles. We are pleased that you have taken the time to visit this special exhibit, and invite you to peruse the hundreds of titles and publishers on display. This catalogue provides you with their company, contact, and other relevant information so you can contact them after the show has ended. In addition, all titles will be included on a New Title Showcase searchable database, and can be on the Internet at http://NewTitleShowcase.com. Please take this catalogue with our compliments, and keep it along with your London Book Fair show directory as a record of what you saw, and whom you visited at the 2013 Fair. At the conclusion of the London Book Fair, this catalogue will be available on the London Book Fair web site (www.londonbookfair.co.uk), and the Combined Book Exhibit web site (www.combinedbook.com) in pdf format. Once again, thank you for visiting this showcase, and we hope you have a successful and rewarding experience at this years show. Jacks Thomas Jon Malinowski Group Exhibition Director President London Book Fair Combined Book Exhibit London Book Fair New Title Showcase 2013 Afflatus Press, Imagine Creative Ang'dora Productions, LLC Technology 15275 Collier Blvd 201-300, Naples, Florida USA 34119. Tel: 2392509220;Email: [email protected] 1000 Universal Studios Plaza, Sound Stage 17, Orlando, Web: www.readourwrites.com Florida USA 32819.
    [Show full text]
  • Trustees' Annual Report and Financial Statements 31 March 2016
    THE FRANCIS CRICK INSTITUTE LIMITED A COMPANY LIMITED BY SHARES TRUSTEES’ ANNUAL REPORT AND FINANCIAL STATEMENTS 31 MARCH 2016 Charity registration number: 1140062 Company registration number: 6885462 The Francis Crick Institute Accounts 2016 CONTENTS INSIDE THIS REPORT Trustees’ report (incorporating the Strategic report and Directors’ report) 1 Independent auditor’s report 12 Consolidated statement of financial activities 13 Balance sheets 14 Cash flow statements 15 Notes to the financial statements 16 1 TRUSTEES’ REPORT (INCORPORATING THE STRATEGIC REPORT AND DIRECTORS’ REPORT) The trustees present their annual directors’ report together with the consolidated financial statements for the charity and its subsidiary (together, ‘the Group’) for the year ended 31 March 2016, which are prepared to meet the requirements for a directors’ report and financial statements for Companies Act purposes. The financial statements comply with the Charities Act 2011, the Companies Act 2006, and the Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK (FRS102) effective 1 January 2015 (Charity SORP). The trustees’ report includes the additional content required of larger charities. REFERENCE AND ADMINISTRATIVE DETAILS The Francis Crick Institute Limited (‘the charity’, ‘the Institute’ or ‘the Crick) is registered with the Charity Commission, charity number 1140062. The charity has operated and continues to operate under the name of the Francis Crick
    [Show full text]
  • Calne,R 3.Pdf
    © Oxford Brookes University 2012 The Royal College of Physicians and Oxford Brookes University Medical Sciences Video Archive MSVA 154 Professor Sir Roy Calne FRS in interview with Dr Max Blythe Trinity Hall, Cambridge 13 December 1996 Interview Three MB Sir Roy, when we came to the end of our interview yesterday, we’d just got to the point where you were waiting to take a Harkness Fellowship in America, in Boston, but in the period of waiting, rather an exciting development occurred. RC Well, it was exciting and disappointing. My boss, John Hopewell, was very enthusiastic about the experiments and he thought that the drug, 6-mercaptopurine, which I’d been using in animals was far better than irradiation, which I also felt, and that he would be agreeable for us to do a human transplant or even several. And we decided that, since we had nothing else to offer patients, this highly experimental procedure was something we could talk to a patient in a sensible way about and see what they felt. A middle-aged lady with polycystic disease of the kidneys, a congenital disease in which the kidneys are full of cysts and both kidneys usually stop working between the ages of forty and fifty, well she had reached the end stage. We didn’t have regular dialysis as an option then, it was just something that was also being thought about, but we did have dialysis. She came in, and when we discussed it with her, she felt that this was her only chance and worth taking and we then waited for a donor.
    [Show full text]
  • Staff Changes Emma Bennett Joined the Academy As Exhibits Regularly in the UK and Europe
    Council Election Nobel Prize Congratulations to the following Fellows who Dr Sydney Brenner were elected to serve as new members of FRS HonFMedSci was awarded The Council with effect from 21 November 2002. Nobel Prize in Physiology or Medicine for 2002 for his research into genetic regulation of organ development and Professor Carol Black programmed cell death. Though now based in California, President, The Royal College of Physicians and Professor of Sydney Brenner’s discoveries whilst working in Cambridge, Rheumatology, Royal Free and University College Medical School UK, laid the foundation for this year’s prize which was awarded jointly to H Robert Horvitz and John E Sulston. Professor Nancy Rothwell MRC Research Professor, University of Manchester Professor Julia Goodfellow Chief Executive, the Biotechnology and Biological Sciences Research Council Professor Colin Bird Sir Douglas Black Formerly Dean of Medicine and Provost of Faculty Group of Medical and Veterinary Medicine, University of Edinburgh Sir Douglas Black: died September 13, 2002. It is with Medical School much sadness that we record the passing of a distinguished Honorary Fellow. The Black report was widely Professor Jonathan Cohen regarded as the most authoritative publication on the link Dean, Brighton & Sussex Medical School between poor health and social deprivation. That it became Professor Thomas Kirkwood so influential was at least in part due to the then Professor of Medicine, University of Newcastle Upon Tyne Government’s efforts to suppress its publication. Council is pleased to announce the appointment of Sir John Skehel, Sir Douglas was a widely respected and much loved FRS FMedSci, as Shadow Vice-President with responsibility for Professor of Medicine at Manchester and later President of non-clinical affairs.
    [Show full text]